<DOC>
	<DOCNO>NCT01179581</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single ascending ( SAD ) multiple ( MD ) oral dos GLPG0634 compare placebo ( without food ) . Also , pharmacokinetics ( PK ) pharmacodynamics ( PD ) GLPG0634 single multiple oral administration evaluate , , applicable , maximum tolerate dose determine .</brief_summary>
	<brief_title>First-in-Human Single Ascending Multiple Dose GLPG0634</brief_title>
	<detailed_description />
	<criteria>healthy male , age 4060 year body mass index ( BMI ) 1830 kg/mÂ² , inclusive . condition might interfere procedure test study smoke drug alcohol abuse</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>